Baricitinib
An orally available small molecule drug with potential anti-inflammatory, immunomodulating, antineoplastic and antiviral activities. Baricitinib is a globally approved treatment for rheumatoid arthritis.
Key facts
| Also Known As | Olumiant |
|---|---|
| Canonical SMILES | CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 |
| CAS Registry Number | 1187594-09-7 |
| DSSTox ID | DTXSID30152228 |
| UNII | ISP4442I3Y |
| Wikidata ID | Q4860707 |